Protalix Biotherapeutics, Inc.
(NYSE Amex Equities : PLX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
IQVIQVIA Holdings, Inc. -0.48%247.520.0%$215.66m
LHLaboratory Corp. of America Holdings 0.61%296.452.3%$181.58m
DGXQuest Diagnostics, Inc. 0.49%141.934.7%$144.30m
AMEHApollo Medical Holdings, Inc. -10.81%88.370.0%$58.30m
NOTVInotiv, Inc. -3.37%26.120.0%$1.56m
PLXProtalix Biotherapeutics, Inc. -4.17%1.5018.6%$1.44m
NRCNational Research Corp. 0.44%52.780.0%$1.39m
QIPTQuipt Home Medical Corp. -0.54%5.520.0%$0.52m
PMDPsychemedics Corp. -0.68%7.350.7%$0.12m

Company Profile

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.